Several widely prescribed drug classes can impair memory, and some are available over the counter. The two most strongly linked to cognitive decline are anticholinergics and benzodiazepines, both of which carry a measurably higher risk of dementia with long-term use. But they’re not the only ones. Statins, beta-blockers, certain antidepressants, and opioids can all affect memory to varying degrees.
Anticholinergics: The Most Common Culprit
Anticholinergic drugs block a brain chemical called acetylcholine, which plays a direct role in learning and memory. What makes this class especially problematic is how many common medications fall into it: allergy pills, sleep aids, bladder control drugs, and older antidepressants all have anticholinergic effects. Many people take one or more without realizing the cognitive cost.
The risk scales with duration. Taking a strong anticholinergic for three or more years is associated with a 54% higher risk of dementia compared to taking the same dose for three months or less. That’s not a small increase, and it’s why the American Geriatrics Society’s Beers Criteria flags antihistamines, bladder medications, and several other anticholinergics as potentially inappropriate for older adults, specifically citing confusion, cognitive impairment, and delirium as concerns.
The strongest anticholinergics include first-generation antihistamines (the kind in many over-the-counter sleep and allergy products), tricyclic antidepressants, and medications for overactive bladder. A key factor is whether the drug crosses from the bloodstream into the brain. Not all anticholinergics do so equally, which is why some cause more noticeable memory problems than others.
Benzodiazepines and Alzheimer’s Risk
Benzodiazepines are prescribed for anxiety, insomnia, and seizures. They work by amplifying the effect of a brain chemical called GABA, which slows neural activity. That calming effect is the point of the drug, but it also suppresses the brain processes involved in forming and retrieving memories.
Short-term use appears relatively safe. People who took a benzodiazepine for three months or less showed roughly the same dementia risk as people who never took one. But the numbers climb steeply from there: three to six months of use raised Alzheimer’s risk by about 32%, and use beyond six months raised it by 84%. A large case-control study published in The BMJ found that overall, past benzodiazepine use was associated with a 43% to 51% increased risk of Alzheimer’s disease.
The type of benzodiazepine matters too. Long-acting formulations like diazepam carried a higher risk (70% increase) than short-acting ones like lorazepam or alprazolam (43% increase). This likely reflects greater cumulative exposure to the drug’s brain-slowing effects.
Antidepressants: Older Types Are Worse
Not all antidepressants affect memory equally. Tricyclic antidepressants, an older class, have strong anticholinergic properties and show the clearest cognitive side effects. In a study comparing people with remitted depression, those taking tricyclics performed significantly worse on tests of visual memory and executive function (the ability to plan, focus, and switch between tasks) compared to healthy controls. People on newer antidepressants showed impaired visual memory but preserved executive function.
Depression itself impairs verbal memory even after symptoms improve, which complicates the picture. But the research suggests that tricyclics add a layer of drug-induced cognitive impairment on top of what the condition itself causes. If you’re taking a tricyclic and noticing memory problems, it’s worth knowing that newer options with lower anticholinergic burden exist.
Sleep Medications
Prescription sleep aids, particularly the “Z-drugs” like zolpidem, alter sleep architecture in ways that can affect how your brain processes memories overnight. Zolpidem changes the timing and quality of sleep spindles, the brief bursts of brain activity during sleep that help consolidate new memories. It also reduces theta and delta wave activity, brain rhythms tied to deep, restorative sleep.
The cognitive effects of Z-drugs are complicated. Lab studies show that zolpidem can actually improve overnight memory retention by optimizing spindle timing in some people. But the real-world picture includes well-documented episodes of amnesia, particularly for events that happen after taking the drug and before falling asleep. Over-the-counter sleep aids present a different problem entirely: most contain first-generation antihistamines with anticholinergic effects, making them a concern for the reasons described above.
Blood Pressure Medications
Among blood pressure drugs, beta-blockers are the class most associated with cognitive side effects. The key distinction is whether a specific beta-blocker is lipophilic (fat-soluble) or hydrophilic (water-soluble). Lipophilic beta-blockers like propranolol cross into the brain more easily and have long been linked to side effects including sleep disturbances, depression, fatigue, and mental fogginess. Hydrophilic beta-blockers are less likely to cause these problems because they stay mostly outside the brain.
If you’re on a beta-blocker and experiencing memory issues, asking about switching to a hydrophilic option is a reasonable conversation to have with your prescriber.
Statins and Cholesterol Drugs
The FDA requires statin labels to mention memory loss and confusion as potential side effects. However, the agency describes these effects as “generally non-serious and reversible” after stopping the medication. This is an important distinction from the dementia risk associated with anticholinergics and benzodiazepines. Statin-related memory complaints tend to be mild, scattered, and temporary rather than progressive.
Because statins provide significant cardiovascular protection, the risk-benefit calculation often still favors continuing the medication. But the labeling change means your doctor should take a cognitive complaint seriously if you’re on a statin, rather than dismissing it.
Other Medications on the Watch List
The Beers Criteria, which is the standard reference for medications that pose risks to older adults, flags several additional categories:
- Antipsychotics (any type): associated with stroke risk, cognitive decline, and delirium
- Opioid pain medications: can cause neurotoxicity and delirium, with cognitive impairment that may persist into early recovery
- Anti-nausea drugs like dimenhydrinate: carry anticholinergic effects that cause confusion and cognitive impairment
- Certain muscle relaxants and anti-spasm drugs: also have anticholinergic properties
Is the Damage Reversible?
For most medications, the cognitive effects improve after you stop taking them or switch to an alternative. Statin-related memory issues typically resolve after discontinuation. Benzodiazepine-related fogginess often clears within weeks to months, though the long-term dementia risk from extended past use is a separate concern that may not be reversible. Opioid-related cognitive impairment can improve with sustained abstinence, though recovery timelines vary and some people benefit from structured cognitive rehabilitation over several weeks.
Anticholinergics present the most uncertain picture. Short-term use appears to cause reversible effects, but the 54% increased dementia risk seen with three or more years of use suggests that prolonged exposure may cause lasting changes. The practical takeaway: the sooner you identify a problematic medication and explore alternatives, the better your chances of full cognitive recovery.
Lower-Risk Alternatives Exist
For many of the conditions treated by high-risk medications, alternatives with fewer cognitive side effects are available. Overactive bladder is a good example. The standard medications are anticholinergics, but a newer class called beta-3 agonists (mirabegron and vibegron) works through a completely different mechanism and is not associated with cognitive decline. Physical therapy and lifestyle changes are considered first-line treatments before any medication. For cases that don’t respond to pills, options like Botox injections into the bladder wall or nerve stimulation devices offer effective relief without anticholinergic exposure.
Similarly, newer antidepressants carry a lighter cognitive burden than tricyclics, and hydrophilic beta-blockers are available as alternatives to lipophilic ones. If you’re taking any medication on this list and noticing memory problems, the issue may be solvable without giving up treatment for the underlying condition.